【结 构 式】 |
【分子编号】42266 【品名】4-methyl-3-penten-2-one 【CA登记号】141-79-7 |
【 分 子 式 】C6H10O 【 分 子 量 】98.1448 【元素组成】C 73.43% H 10.27% O 16.3% |
合成路线1
该中间体在本合成路线中的序号:(II)Synthesis of aldehyde intermediate (IX): The condensation of 1-tert-butoxy-4-chlorobutane (I) with 4-methyl-3-penten-2-one (II) by means of Mg in hot THF gives the 2-octanone (III), which is condensed with hexafluoroacetone (IV) by means of diethyl chlorophosphate and LDA in THF to yield the fluorinated alkynol (V). Hydrogenation of the triple bond of (V) with H2 and Lindlar catalyst affords the cis-alkene (VI), which is deprotected with sulfuric acid to provide the fluorinated diol (VII). Finally, the primary alcohol of (VII) is oxidized to the corresponding aldehyde (VIII) with NaOCl and tempo, which is silylated with Tes-Cl and TEA to afford the desired intermediate (IX).
【1】 Wirz, B.; Hilpert, H.; Novel versatile approach to an enantiopure 19-nor, des-C,D vitamin D-3 derivative. Tetrahedron 2001, 57, 4, 681. |
【2】 Hilpert, H.; Wirz, B. (F. Hoffmann-La Roche AG); New process for the preparation of retiferol derivs.. EP 1094060 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 49032 | tert-butyl 4-chlorobutyl ether; 1-(tert-butoxy)-4-chlorobutane | C8H17ClO | 详情 | 详情 | |
(II) | 42266 | 4-methyl-3-penten-2-one | 141-79-7 | C6H10O | 详情 | 详情 |
(III) | 49033 | 8-(tert-butoxy)-4,4-dimethyl-2-octanone | C14H28O2 | 详情 | 详情 | |
(IV) | 44260 | 1,1,1,3,3,3-hexafluoroacetone | 684-16-2 | C3F6O | 详情 | 详情 |
(V) | 49034 | 10-(tert-butoxy)-1,1,1-trifluoro-6,6-dimethyl-2-(trifluoromethyl)-3-decyn-2-ol | C17H26F6O2 | 详情 | 详情 | |
(VI) | 49035 | (Z)-10-(tert-butoxy)-1,1,1-trifluoro-6,6-dimethyl-2-(trifluoromethyl)-3-decen-2-ol | C17H28F6O2 | 详情 | 详情 | |
(VII) | 49036 | (Z)-10,10,10-trifluoro-5,5-dimethyl-9-(trifluoromethyl)-7-decene-1,9-diol | C13H20F6O2 | 详情 | 详情 | |
(VIII) | 49037 | (Z)-10,10,10-trifluoro-9-hydroxy-5,5-dimethyl-9-(trifluoromethyl)-7-decenal | C13H18F6O2 | 详情 | 详情 | |
(IX) | 49038 | (Z)-10,10,10-trifluoro-5,5-dimethyl-9-[(triethylsilyl)oxy]-9-(trifluoromethyl)-7-decenal | C19H32F6O2Si | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(II)Thiophenol (I) is treated with mesityl oxide (II) in CHCl3 and Et3N to yield derivative (III), which is then converted into alcohol (IV) by means of methylmagnesium iodide in Et2O. Cyclization of (IV) by means of AlCl3 in CS2 affords benzothiopyrane derivative (V) (1), which is nitrated by means of HNO3 and Ac2O or HOAc followed by treatment with Na2CO3 to provide (VI). Nitro derivative (VI) is then reduced with TiCl3 and HOAc or HCl and treated with NaOH to yield (VII). Amine (VII) is finally acylated with acid chloride (VIII) in benzene and pyridine.
【1】 Spruce, L.W.; et al.; Novel heteroarotinoids: Synthesis and biological activity. J Med Chem 1991, 34, 1, 430. |
【2】 Lu, S.; Zacheis, D.; Dhar, A.; et al.; Heteroarotinoids inhibit head and neck cancer cell lines in vitro and in vivo through both RAR and RXR retinoic acid receptors. J Med Chem 1999, 42, 21, 4434. |
【3】 Nelson, E.C.; Madler, M.M.; Subramanian, S.; Birckbichler, P.J.; Berlin, K.D.; Patterson, M.K. Jr.; Benbrook, D.M. (Oklahoma State University); Heteroarotinoids - Anticancer agents with receptor specificity and TGASE activity. WO 9807716 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 12951 | Benzenethiol; Phenylmercaptan; Phenylhydrosulfide | 108-98-5 | C6H6S | 详情 | 详情 |
(II) | 42266 | 4-methyl-3-penten-2-one | 141-79-7 | C6H10O | 详情 | 详情 |
(III) | 42267 | 4-methyl-4-(phenylsulfanyl)-2-pentanone | C12H16OS | 详情 | 详情 | |
(IV) | 42268 | 2,4-dimethyl-4-(phenylsulfanyl)-2-pentanol | C13H20OS | 详情 | 详情 | |
(V) | 42269 | 2,2,4,4-tetramethylthiochromane | C13H18S | 详情 | 详情 | |
(VI) | 42270 | 2,2,4,4-tetramethyl-6-nitrothiochromane | C13H17NO2S | 详情 | 详情 | |
(VII) | 42271 | 2,2,4,4-tetramethyl-6-thiochromanamine; 2,2,4,4-tetramethyl-3,4-dihydro-2H-thiochromen-6-ylamine | C13H19NS | 详情 | 详情 | |
(VIII) | 42272 | 4-acetylbenzoyl chloride | C9H7ClO2 | 详情 | 详情 |